Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2010
06/23/2010CN101748030A Preparation method of nourishing and health-care liquor
06/23/2010CN101747287A 2-oxo-1,3-O-aza-cyclopentane-4-carboxamide derivative and application thereof in preparation of immunosuppressant
06/23/2010CN101747259A Azasugars compounds, synthesis method and applications thereof
06/23/2010CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant
06/23/2010CN101745074A Chinese medicinal herb for enhancing immunity
06/23/2010CN101745068A Chinese medicinal lotion for treating scrotal eczema
06/23/2010CN101745031A Ointment for tonifying kidney and improving eyesight and preparation method thereof
06/23/2010CN101745024A Quality control method for Shenmai injection
06/23/2010CN101745023A Compound bee product and preparation method thereof
06/23/2010CN101744985A Medicament for treating child repetitive respiratory infection and low immunity
06/23/2010CN101744975A Method for detecting compound lightyellow sophora root injection
06/23/2010CN101744964A Immunity adjusting raw material extracted from plant by supercritical CO2 extraction method and preparation method thereof
06/23/2010CN101744947A Chinese herbal medicine composition with function of strengthening immunity
06/23/2010CN101744915A Medicament for treating maternal-fetal ABO incompatibility
06/23/2010CN101744914A Method for rapidly detecting quality of anti-hepatitis-jaundice injection
06/23/2010CN101744904A Chinese traditional medicine capable of improving immunity of immature rabbits
06/23/2010CN101744897A External medicine preparation for treating acute and chronic eczema
06/23/2010CN101744866A Traditional Chinese medicine composition for preventing and treating culture diseases of livestock and poultry, preparation method and application thereof
06/23/2010CN101744855A External Chinese medicinal ointment for treating chronic eczema
06/23/2010CN101744852A Preparation method of acanthopanax effervescent tablet and products thereof
06/23/2010CN101744846A Edible mycotic composite amylase nutritional agent
06/23/2010CN101744841A Collins john kevin; o'sullivan gerald christopher; o'mahony liam; shanahan fergus
06/23/2010CN101744792A Fluticasone propionate and salmeterol xinafoate compound dry powder inhalation and preparation technology thereof
06/23/2010CN101744649A System for transferring anti-AIDS vaccine
06/23/2010CN101744285A Method for preparing emulsified and gelatinized functional fatty acid carrier
06/23/2010CN101037651B Lucidum mushroom health wine and production method thereof
06/22/2010US7741440 Apoptin-associating protein
06/22/2010US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride
06/22/2010US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation
06/22/2010US7741330 1-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)-2,3-dihydroxypropan-1-one, used for the treatment of autoimmune diseases, inflammatory diseases, allergy disorders, B-cell proliferative disorders, or thromboembolic disorders
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741297 Cpg sites; point mutations; immunogens; cancer
06/22/2010US7741292 Method of inhibiting the emigration of cells from the intravascular compartment into tissues
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740841 Therapeutic method for reducing angiogenesis
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2552218C Left-side glucose lipid a analogue
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2401593C Infusion packet with useful and decorative elements, support member, delivery system and method
06/22/2010CA2242878C Induction of immune response against desired determinants
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/17/2010WO2010068810A2 Certain substituted amides, method of making, and method of use thereof
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010067882A1 Pharmaceutical composition for treatment of cancer and asthma
06/17/2010WO2010067671A1 Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
06/17/2010WO2010067286A2 IgE CH3 PEPTIDE VACCINE
06/17/2010WO2010066100A1 The 2-oxo-1,3-oxaazocyclopentane-4-formamide derivatives and their uses as the immunosuppressant.
06/17/2010WO2010066049A1 Methods and systems for inducing immunologic tolerance to non-self antigens
06/17/2010WO2010028079A3 Synthetic methods and derivatives of triphosphate oligonucleotides
06/17/2010WO2009136296A3 Compositions obtained from chlorella extract having immunomodulating properties
06/17/2010WO2009101059A3 Methods of using cadherin 11 (cdh11) antagonists
06/17/2010US20100152446 Piperidine Derivatives
06/17/2010US20100152281 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152213 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010US20100152201 Oligomer-Antihistamine Conjugates
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152172 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152151 Tgr5 modulators and methods of use therof
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152133 Use of chitosans to increase nail growth rate
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100152105 Use of rapamycin derivatives in chronic rejection
06/17/2010US20100151507 Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same
06/17/2010US20100151031 Discrete size and shape specific organic nanoparticles designed to elicit an immune response
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100151000 Compositions and methods for modulating immune responses
06/17/2010US20100150999 Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
06/17/2010US20100150990 Treatment of inflammation and/or endotoxic shock
06/17/2010US20100150969 immune response
06/17/2010US20100150968 Dna vectors
06/17/2010US20100150960 Compositions and methods for chitosan enhanced immune response
06/17/2010US20100150957 Peptides for active anti-cytokine immunization
06/17/2010US20100150950 Human antibodies that bind cd70 and uses thereof
06/17/2010US20100150947 Tolerance induction and maintenance in hematopoietic stem cell allografts
06/17/2010US20100150936 Prevention of rash in patients undergoing anti-egfr therapy
06/17/2010US20100150927 Cell death inducer
06/17/2010US20100150918 Cross-species-specific binding domain
1 ... 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 ... 1172